Mechanism of Hypoxia-Inducible Factor-1alpha Over- Expression and Molecular-Target Therapy for Hepatocellular Carcinoma

Codice QR

Mechanism of Hypoxia-Inducible Factor-1alpha Over- Expression and Molecular-Target Therapy for Hepatocellular Carcinoma

None

Salvato in:

Dettagli Bibliografici
Autori principali:	Yao, Dengfu, Yao, Min, Li, Shanshan, Dong, Zhizhen
Natura:	Elettronico Capitolo di libro
Lingua:	inglese
Pubblicazione:	IntechOpen 2011
Soggetti:	Health Sciences
Accesso online:	https://www.intechopen.com/chapters/17926
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Expression of hypoxia-induced factor-1 alpha in early-stage and in metastatic oral squamous cell carcinoma
di: Maisa Ribeiro, et al.
Pubblicazione: (2017-04-01)

Expression of hypoxia inducible factor 1 alpha and its clinical significance in esophageal carcinoma: A meta-analysis
di: Shao Wu Jing, et al.
Pubblicazione: (2017-07-01)

Upregulated Krüppel-like factor 5 promotes hepatocellular carcinoma progression by activating Wnt3a signaling
di: Wenli Sai, et al.
Pubblicazione: (2025-11-01)

ROS-Responsive Nanosystem Targeted Co-Delivery YC-1 and Regorafenib to Alleviate Hypoxia Enhancing Hepatocellular Carcinoma Therapy
di: Song L, et al.
Pubblicazione: (2025-07-01)

Histone deacetylase 5 promotes the migration and invasion of hepatocellular carcinoma via increasing the transcription of hypoxia-inducible factor-1α under hypoxia condition
di: Ming Ye, et al.
Pubblicazione: (2017-06-01)

Molecular Subtyping of Hepatocellular Carcinoma via Lysosome-Related Genes for Prognosis and Therapy Prediction
di: Yao Y, et al.
Pubblicazione: (2025-07-01)

The Involvement of the ERK-Hypoxia-Angiogenesis Signaling Axis and HIF-1 in Hepatocellular Carcinoma
di: Mylonis, Ilias, et al.
Pubblicazione: (2012)

Molecular Genetics and Genomics of Hepatocellular Carcinoma
di: Colak, Dilek, et al.
Pubblicazione: (2012)

Hypoxia effect on proliferative activity of cells in orthotopic xenograft of hepatocellular carcinoma of the liver in the experiment
di: T. M. Kecheryukova, et al.
Pubblicazione: (2024-05-01)

Gamma-irradiated β-glucan modulates signaling molecular targets of hepatocellular carcinoma in rats
di: Sawsan M Elsonbaty, et al.
Pubblicazione: (2017-08-01)

Novel Therapeutic Targets for Hepatocellular Carcinoma Treatment
di: Chen, Yangchao, et al.
Pubblicazione: (2012)

Research progress on molecular mechanisms of hepatocellular carcinoma induced by heavy metal cadmium exposure
di: An Hongmei, et al.
Pubblicazione: (2025-06-01)

Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients
di: Rino A Gani, et al.
Pubblicazione: (2016-05-01)

Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients
di: Rino A Gani, et al.
Pubblicazione: (2016-05-01)

Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients
di: Rino A Gani, et al.
Pubblicazione: (2016-05-01)

Identification of key molecular targets for stachyose in hepatocellular carcinoma: focus on STAT3 and FN1
di: Haihua Chen, et al.
Pubblicazione: (2025-07-01)

CARDIOCYTOPROTECTION PERSPECTIVES WITH ISCHEMIC PRECONDITIONING: HYPOXIA-INDUCED FACTOR 1 — POSSIBLE MOLECULAR MECHANISM AND TARGET FOR PHARMACOTHERAPY
di: A. V. Lyubimov, et al.
Pubblicazione: (2017-12-01)

Therapeutic Approaches for Targeting Hypoxia- Inducible Factor in Multiple Myeloma
di: Kirito, Keita
Pubblicazione: (2012)

The expression level and clinical significance of lncRNA X91348 in hepatocellular carcinoma
di: Zhen Zeng, et al.
Pubblicazione: (2019-12-01)

MOLECULAR GENETIC ASPECTS OF HEPATOCELLULAR CARCINOMA PATHOGENESIS AND CURRENT OPTIONS OF DRUG THERAPY
di: A. S. Makarova
Pubblicazione: (2017-12-01)

EpCAM as a novel therapeutic target for hepatocellular carcinoma
di: Vasanthakumar S, et al.
Pubblicazione: (2017-07-01)

Immunobiology of Monocytes/Macrophages in Hepatocellular Carcinoma
di: Kuang, Dong-Ming, et al.
Pubblicazione: (2012)

Expression of Fra-1 in human hepatocellular carcinoma and its prognostic significance
di: Xiao-Qiang Gao, et al.
Pubblicazione: (2017-06-01)

The Molecular Pathogenesis of Aflatoxin with Hepatitis B Virus-Infection in Hepatocellular Carcinoma
di: Cao, Hai-Xia, et al.
Pubblicazione: (2011)

Identification and validation of the fibrosis-related molecular subtypes of hepatocellular carcinoma by bioinformatics
di: Ling-li Liu, et al.
Pubblicazione: (2025-06-01)

Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia‐Induced Vulnerabilities in Multiple Myeloma
di: Seiichi Okabe, et al.
Pubblicazione: (2025-06-01)

Impact of the small bowel impassability on expression of the hypoxia-induced factor-1α
di: D. A. Kluiko
Pubblicazione: (2021-10-01)

Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma
di: Rui Liu, et al.
Pubblicazione: (2017-04-01)

Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Study
di: Liu J, et al.
Pubblicazione: (2025-07-01)

Hypoxia, cuproptosis, and osteoarthritis: Unraveling the molecular crosstalk
di: Zhanliang Jiang, et al.
Pubblicazione: (2025-09-01)

PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma
di: Ayesha Khalid, et al.
Pubblicazione: (2017-05-01)

The expression of tumor progression markers in hepatocellular and cholangiocellular liver carcinomas of different sizes
di: V. A. Tumanskiy, et al.
Pubblicazione: (2015-08-01)

RETRACTED ARTICLE: Expression tendency and prognostic value of TCF21 in hepatocellular carcinoma
di: Wei Lu, et al.
Pubblicazione: (2019-12-01)

Fusion transcripts landscape in hepatocellular carcinoma and potential impact on the expression of fusion partners
di: Yasemin Öztemur Islakoğlu, et al.
Pubblicazione: (2025-12-01)

Intratumor Rhodococcus sp. B513 drives DEN-induced hepatocellular carcinoma progression by modulating gut microbiota and angiogenesis
di: Qisha Liu, et al.
Pubblicazione: (2025-01-01)

Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway
di: Yongfei He, et al.
Pubblicazione: (2025-07-01)

Potential Therapeutic Molecular Targets for Nasopharyngeal Carcinoma
di: Chen, Shih-Shun
Pubblicazione: (2012)

New Molecular Biomarkers Candidates for the Development of Multiparametric Platforms for Hepatocellular Carcinoma Diagnosis, Prognosis and Personalised Therapy
di: Serafino, Annalucia, et al.
Pubblicazione: (2012)

Role of cytokines in hepatocellular carcinoma
di: T. Aghayev, et al.
Pubblicazione: (2022-11-01)

Hepatocellular Carcinoma: A Review
di: Tarana Gupta
Pubblicazione: (2020-09-01)